HomeAI · summaries
Storia in 2 fonti
Apollo Hospitals Q4 Results: Cons PAT jumps 36% YoY to Rs 529 crore, revenue rises 18%; Rs 10 per share dividend declared
Apollo Hospitals reported strong Q4 FY26 results: consolidated PAT surged 36% YoY to Rs 529 crore, and revenue increased 18% to Rs 6,605 crore. EBITDA grew 31% to Rs 1,011 crore. The company declared a Rs 10 dividend.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Apollo Hospitals Q4 Results: Cons PAT jumps 36% YoY to Rs 529 crore, revenue rises 18%; Rs 10 per share dividend declared
Apollo Hospitals reported strong Q4 FY26 results: consolidated PAT surged 36% YoY to Rs 529 crore, and revenue increased 18% to Rs 6,605 crore. EBITDA grew 31% to Rs 1,011 crore.…
- ·
thehindubusinessline.com
Apollo Hospitals Q4FY26 net profit up 36% at ₹529 crore
Apollo Hospitals reports a 36% rise in Q4FY26 net profit, plans merger with Cloudnine for enhanced maternity and fertility services.
- ·
Apollo Hospitals FY26 profit jumps 34% to Rs 1,942 crore on growth across core businesses
Apollo Hospitals announced robust financial results for the fourth quarter and the full fiscal year 2026. Consolidated revenue and net profit saw significant year-on-year…
- ·
Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividend
Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while revenue declined 6% from Rs 15,520 crore…
- ·
Broker’s call: Apollo Hospitals (Long)
Equirus Securities recommends a long position on Apollo Hospitals, targeting ₹9,444 with strong revenue growth projections through FY28.
- ·
Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announced
Divi's Laboratories Q4 Results: Divi's Laboratories announced strong financial results for the March quarter. Net profit rose 13% to Rs 751 crore. Revenue from operations…